Literature DB >> 21808237

Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis.

Shuji Mikami1, Ken-Ichi Katsube, Mototsugu Oya, Masaru Ishida, Takeo Kosaka, Ryuichi Mizuno, Makio Mukai, Yasunori Okada.   

Abstract

The Snail family transcription factors have been proposed as important mediators of epithelial-mesenchymal transition because of their role in down-regulation of E-cadherin and up-regulation of matrix metalloproteinases (MMPs). The present study was undertaken to investigate the expression of Snail, Slug and their associations with cancer invasion and prognosis in renal cell carcinomas (RCCs). Ninety-seven primary RCCs were analyzed for the protein expression of Snail, Slug, MMP2 and MMP9 by immunohistochemistry. Snail protein expression level was positively correlated with pathological tumor stage, histological grade and the presence of sarcomatoid carcinoma. On the contrary, Slug protein expression level was negatively correlated with pathological tumor stage, suggesting that Slug was down-regulated in advanced RCCs. Because Snail was positively associated with malignant potential of RCCs, involvement of Snail in the invasiveness of an RCC cell line 786-O was examined in the Matrigel invasion assay by down-regulating the gene expression with small interfering RNA (siRNA). Targeting the Snail, not Slug, expression in 786-O cells with siRNA caused down-regulation of the gene expression of Snail, vimentin, MMP2 and MMP9, but up-regulated the E-cadherin. Invasion of the cells through Matrigel in vitro was inhibited under this condition. Furthermore, expression levels of MMP2 and MMP9 were positively correlated with pathological tumor stage and the presence of sarcomatoid carcinoma. Statistical analysis indicated that elevated Snail, MMP2 and MMP9 protein expression are significantly worse predictors of disease-free and disease-specific survival of the patients with RCC. In conclusion, these data suggest that Snail has an important role in invasion and metastasis, and that silencing the gene may be a potential therapeutic target in RCCs.
© 2011 USCAP, Inc All rights reserved

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21808237     DOI: 10.1038/labinvest.2011.111

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  51 in total

1.  Prognostic value of multiple epithelial mesenchymal transition-associated proteins in intrahepatic cholangiocarcinoma.

Authors:  Xiangguo Tian; Zhixin Cao; Qian Ding; Zhen Li; Chunqing Zhang
Journal:  Oncol Lett       Date:  2019-06-24       Impact factor: 2.967

2.  Expression of MMP-9 and WAVE3 in colorectal cancer and its relationship to clinicopathological features.

Authors:  Yi Zhang; Xiao-Ya Guan; Bin Dong; Min Zhao; Jian-Hui Wu; Xiu-Yun Tian; Chun-Yi Hao
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-18       Impact factor: 4.553

3.  Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients.

Authors:  Shuji Mikami; Mototsugu Oya; Takeo Kosaka; Ryuichi Mizuno; Yasumasa Miyazaki; Yasufumi Sato; Yasunori Okada
Journal:  Lab Invest       Date:  2017-03-13       Impact factor: 5.662

4.  Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.

Authors:  Fumi Kawakami; Kanishka Sircar; Jaime Rodriguez-Canales; Bryan M Fellman; Diana L Urbauer; Pheroze Tamboli; Nizar M Tannir; Eric Jonasch; Ignacio I Wistuba; Christopher G Wood; Jose A Karam
Journal:  Cancer       Date:  2017-08-22       Impact factor: 6.860

5.  Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.

Authors:  Darya Buehler; Heather Hardin; Weihua Shan; Celina Montemayor-Garcia; Patrick S Rush; Sofia Asioli; Herbert Chen; Ricardo V Lloyd
Journal:  Mod Pathol       Date:  2012-08-17       Impact factor: 7.842

6.  Chromosomal imbalances revealed in primary renal cell carcinomas by comparative genomic hybridization.

Authors:  Xue-Ling Kang; Hong Zou; Li Juan Pang; Wen Hao Hu; Jin Zhao; Yan Qi; Chun-Xia Liu; Jian Ming Hu; Jing-Xia Tang; Hong An Li; Wei Hua Liang; Xiang-Lin Yuan; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 7.  Invasion and metastasis of renal cell carcinoma.

Authors:  Shuji Mikami; Mototsugu Oya; Ryuichi Mizuno; Takeo Kosaka; Ken-ichi Katsube; Yasunori Okada
Journal:  Med Mol Morphol       Date:  2013-11-09       Impact factor: 2.309

Review 8.  Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy.

Authors:  Francesco Piva; Matteo Giulietti; Matteo Santoni; Giulia Occhipinti; Marina Scarpelli; Antonio Lopez-Beltran; Liang Cheng; Giovanni Principato; Rodolfo Montironi
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

9.  Synergistic effects of snail and quercetin on renal cell carcinoma Caki-2 by altering AKT/mTOR/ERK1/2 signaling pathways.

Authors:  Fan-Dong Meng; Yan Li; Xin Tian; Ping Ma; Cheng-Guang Sui; Li-Ye Fu; You-Hong Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  Up-regulation of E-cadherin by saRNA inhibits the migration and invasion of renal carcinoma cells.

Authors:  Jun Dai; Hongchao He; Dengqiang Lin; Chenghe Wang; Yu Zhu; Danfeng Xu
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.